GlucoTrack (NASDAQ:GCTK) Stock Price Up 9% – Here’s What Happened

GlucoTrack, Inc. (NASDAQ:GCTK) rose 9% during trading on Wednesday . The company traded as high as $0.35 and last traded at $0.3477. Approximately 262,735 shares were traded during trading, a decline of 70% from the average session volume of 864,733 shares. The stock had previously closed at $0.3190.

Analyst Ratings Changes

GCTK has been the subject of a number of recent analyst reports. Wall Street Zen raised shares of GlucoTrack to a “sell” rating in a report on Saturday, May 30th. Weiss Ratings reiterated a “sell (e+)” rating on shares of GlucoTrack in a report on Tuesday, April 21st. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock has an average rating of “Sell”.

GlucoTrack Stock Performance

The company has a market capitalization of $2.00 million, a price-to-earnings ratio of -0.02 and a beta of 0.77. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.08. The stock has a 50-day simple moving average of $0.57 and a 200-day simple moving average of $1.67.

Institutional Trading of GlucoTrack

Several institutional investors have recently added to or reduced their stakes in GCTK. Bank of America Corp DE grew its holdings in GlucoTrack by 102,125.0% during the 2nd quarter. Bank of America Corp DE now owns 4,089 shares of the company’s stock worth $25,000 after acquiring an additional 4,085 shares in the last quarter. Boothbay Fund Management LLC acquired a new stake in shares of GlucoTrack in the 4th quarter valued at about $52,000. Finally, Ikarian Capital LLC bought a new position in shares of GlucoTrack during the fourth quarter worth about $177,000. 10.92% of the stock is owned by institutional investors and hedge funds.

About GlucoTrack

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc and changed its name to GlucoTrack, Inc in November 2021. GlucoTrack, Inc was founded in 2001 and is based in Rutherford, New Jersey.